Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay
Journal of Medical Virology · 2023
DOI: 10.1002/jmv.29215 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Yuning Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reagent Research and Development, Shenzhen YHLO Biotech Co., Ltd., Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Influenza, Human, COVID-19, Orthomyxoviridae. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
Respiratory tract infections are associated with the most common diseases transmitted among people and remain a huge threat to global public health. Rapid and sensitive diagnosis of causative agents is critical for timely treatment and disease control. Here, we developed a novel method based on recombinase polymerase amplification (RPA) combined with CRISPR‐Cas12a to detect three viral pathogens, including SARS‐CoV‐2, influenza A, and influenza B, which cause similar symptom complexes of flu cold in the respiratory tract. The detection method can be completed within 1 h, which is faster than other standard detection methods, and the limit of detection is approximately 10 2 copies/μL. Additionally, this detection system is highly specific and there is no cross‐reactivity with other common respiratory tract pathogens. Based on this assay, we further developed a more simplified RPA/CRISPR‐Cas12a system combined with lateral flow assay on a manual microfluidic chip, which can simultaneously detect these three viruses. This low‐cost detection system is rapid and sensitive, which could be applied in the field and resource‐limited areas without bulky and expensive instruments, providing powerful tools for the point‐of‐care diagnostic.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Reagent Research and Development, Shenzhen YHLO Biotech Co., Ltd., Shenzhen, Guangdong, China.
- Hunan Key Laboratory of Biomedical Nanomaterials and Devices, College of Life Science and Chemistry, Hunan University of Technology, Zhuzhou, Hunan, China.
- Department of Biomedical Engineering, The Key Laboratory for Biomedical Photonics of MOE at Wuhan National Laboratory for Optoelectronics-Hubei Bioinformatics & Molecular Imaging Key Laboratory, Systems Biology Theme, H…
ORCID-Profile: Yuning Wang
Zitieren
APA
Wang, Y., Wu, L., Yu, X., Wang, G., Pan, T., Huang, Z., Cui, T., Huang, T., Huang, Z., Nie, L., & Qian, C. (2023). Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay. Journal of Medical Virology. https://doi.org/10.1002/jmv.29215
Vancouver
Wang Y, Wu L, Yu X, Wang G, Pan T, Huang Z, et al. Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay. Journal of Medical Virology. 2023. doi:10.1002/jmv.29215
BibTeX
@article{Wang2023,
author = {Wang, Yuning and Wu, Liqiang and Yu, Xiaomei and Wang, Gang and Pan, Ting and Huang, Zhao and Cui, Ting and Huang, Tianxun and Huang, Zhentao and Nie, Libo and Qian, Chungen},
title = {Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay},
journal = {Journal of Medical Virology},
year = {2023},
doi = {10.1002/jmv.29215}
}
EUVIMED